Ovarian cancer microenvironment: implications for cancer dissemination and chemoresistance acquisition
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://link.springer.com/content/pdf/10.1007/s10555-013-9456-2.pdf
Reference217 articles.
1. Colombo, N., Van, G. T., Parma, G., Amant, F., Gatta, G., Sessa, C., et al. (2006). Ovarian Cancer Critical Reviews Oncology/Hematology, 60(2), 159–179.
2. Hennessy, B. T., Coleman, R. L., & Markman, M. (2009). Ovarian cancer. Lancet, 374(9698), 1371–1382.
3. Romero, I., & Bast, R. C., Jr. (2012). Minireview: human ovarian cancer: biology, current management, and paths to personalizing therapy. Endocrinology, 153(4), 1593–1602.
4. Vaughan, S., Coward, J. I., Bast, R. C., Jr., Berchuck, A., Berek, J. S., Brenton, J. D., et al. (2011). Rethinking ovarian cancer: recommendations for improving outcomes. Nature Reviews Cancer, 11(10), 719–725.
5. Shih, I., & Kurman, R. J. (2004). Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. The American Journal of Pathology, 164(5), 1511–1518.
Cited by 147 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Identification of a cancer associated fibroblasts-related index to predict prognosis and immune landscape in ovarian cancer;Scientific Reports;2023-12-07
2. Snail transcription factors as key regulators of chemoresistance, stemness and metastasis of ovarian cancer cells;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-11
3. Ascites in malignant ovarian cancer confer ovarian cancer cells chemoresistance to platinum. Combination treatment with crizotinib and 2-hydroxyestradiol restores platinum sensitivity;2023-09-24
4. Cancer-mesothelial and cancer-macrophage interactions in the ovarian cancer microenvironment;American Journal of Physiology-Cell Physiology;2023-09-01
5. Potential drug repurposing of ruxolitinib to inhibit the JAK/STAT pathway for the treatment of patients with epithelial ovarian cancer;Journal of Obstetrics and Gynaecology Research;2023-08-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3